Fellowship · Rochester, NY
Sponsored by University of Rochester Medicine
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 1,081 citations · Giby George
NCCN Guidelines® Insights: Older Adult Oncology, Version 1.2021.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 189 citations · Giby George
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022 · 101 citations · Hani Katerji
Circulating Tumor DNA Assessment to Predict Risk of Recurrence After Surgery in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study.
Annals of surgery · 2026 · 10 citations · Giby George
HER2-Low Breast Cancers.
American journal of clinical pathology · 2022 · 81 citations · Hani Katerji
Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low-Expressing Breast Cancer Cohort.
American journal of clinical pathology · 2023 · 58 citations · Hani Katerji
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.
JCO precision oncology · 2022 · 79 citations · Giby George
Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma.
The oncologist · 2024 · 40 citations · Giby George